Hims & Hers Health Inc. buy Citigroup Inc.
Start price
27.02.24
/
50%
€12.65
Target price
27.02.25
€14.74
Performance (%)
-17.31%
Price
03.05.24
€10.46
Summary
This prediction is currently active. The prediction for Hims & Hers Health Inc. disappoints with a performance of -17.31%. This prediction currently runs until 27.02.25. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Hims & Hers Health Inc. | -10.445% | -10.445% |
iShares Core DAX® | -0.922% | -1.993% |
iShares Nasdaq 100 | 0.371% | -0.868% |
iShares Nikkei 225® | 2.224% | -5.187% |
iShares S&P 500 | -0.026% | -0.918% |
Comments by Citigroup_Inc_ for this prediction
In the thread Hims & Hers Health Inc. diskutieren
Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Citigroup Inc. from $12.00 to $16.00. They now have a "buy" rating on the stock.
Ratings data for HIMS provided by MarketBeat